Here’s Why Venture Capitalists Like Juno

Aug. 7 (Bloomberg) -- Juno Therapeutics Scientific Co-Founder Michael Jensen and Second Avenue Partners Co-Founder Nick Hanauer discuss the Juno’s favor with venture capitalists. They speak on “Market Makers.” (Source: Bloomberg)
Oil and Industrial Metals Lead Commodity Rebound
07:54 - Commodity currencies are off to the worst start to a year since the financial crisis amid signs of a slowdown in China, the world’s biggest consumer of raw materials.
  • U.K. Takes Loss in Initial Sale of RBS Stake
  • Libor Rigging Sentence Sends Message to Banks
  • How Restrictions Change the Athens Stock Exchange